Quality of Life (QOL) in Female Patient With Schizophrenia

• Status: Terminated
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The primary objective of this study is to demonstrate clinical and statistical superiority of quetiapine compared to risperidone in Korean version of Heinrich's Quality of Life Scale after 8 weeks trial of drugs.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Inje University
• Treatments: Quetiapine Fumarate; Risperidone

Criteria

Inclusion Criteria:

1. Diagnosis: Schizophrenia (DSM-IV)

2. Female, Age: between 18-60 years

3. Who either need first time treatment with antipsychotic drug or recently

4. Sign written informed consent

Exclusion Criteria:

1. Taking other psychiatric medications during last 30 days

2. Refractory schizophrenia

3. A current medical illness associated with sexual dysfunction

4. Previous history of no response to quetiapine or risperidone treatment

5. Previous enrolment or randomisation of treatment in the present study.

6. Participation in a clinical study during the last 90 days.

7. Pregnancy

8. Alcohol or substance abuser